Clinical TrialsSearch results
Number of results: 1069
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Not yet recruiting
- The impact on human by nature
- Healty person; Improvement of immune system
- Iwata Nakao
- 2022-01-09
Recruiting
- An Observational Study on Effectiveness and Safety of Akalux and BioBlade Laser System Based Illuminox Treatment in Patients with Locally Advanced or Recurrent Head and Neck Cancer
- Unresectable locally advanced or locally recurrent head and neck cancer
- Hanai Nobuhiro
- 2021-12-26
Recruiting
- Gene Alterations for rectum neuroendocrine tumors
- neuroendocrine tumore
- Mizuno Nobumasa
- 2021-12-26
Recruiting
- Investigational Randomized Controlled Trial of Patients with Chronic Thromboembolic Pulmonary Hypertension treated with Riociguat vs Selexipag
- chronic thromboembolic pulmonary hypertension
- Adachi Shiro
- 2021-12-26
No Longer Recruiting
- A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
- Mantle Cell Lymphoma
- Tamura Shinichi
- 2021-12-26
Recruiting
- An open-label, long-term study of imeglimin in type 2 diabetic patients with renal impairment
- Type 2 Diabetes
- Yamamoto Koshi
- 2021-12-23
Recruiting
- Efficacy of transvaginal antibiotic treatment in preventing recurrence after cystectomy for endometriomas.
- Ovarian endometrial cyst
- Osuka Satoko
- 2021-12-21
Not yet recruiting
- General drug use-results survey of UPASITA IV Injection Syringe for Dialysis
- Secondary hyperparathyroidism under hemodialysis
- Dept. Pharmacovigilance
- 2021-12-17
Not yet recruiting
- Study of NIS793 and other novel investigational combinations with SOC anti-cancer therapy for the second line treatment of mCRC
- Metastatic Colorectal Cancer
- Suzuki Kazuyuki
- 2021-12-17
Recruiting
- The application for reduction of cargivers' burden
- Dementia
- Suzuki Yusuke
- 2021-12-12